Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India

Vaccine

Volumn 32, Issue 44, 2014, Pages 5854-5861

  Newman, Peter A ^a   Chakrapani, Venkatesan ^b,c   Weaver, James ^a   Shunmugam, Murali ^b   Rubincam, Clara ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Centre for Sexuality and Health Research and Policy (C SHaRP)   (India)

^c The Humsafar Trust   (India)

Author keywords

Bioethics; HIV vaccine trials; India; Men who have sex with men; Posttrial services; Willingness to participate

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ADULT; ARTICLE; BISEXUAL MALE; CLINICAL TRIAL (TOPIC); EDUCATION; GENDER IDENTITY; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCOME; INDIA; INSURANCE; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MEN WHO HAVE SEX WITH MEN; PATIENT ATTITUDE; PROSTITUTION; UNEMPLOYMENT; WILLINGNESS TO PARTICIPATE; DEMOGRAPHY; MALE HOMOSEXUALITY; MOTIVATION; PATIENT PARTICIPATION; STATISTICS AND NUMERICAL DATA;

ADULT; AIDS VACCINES; DEMOGRAPHY; HOMOSEXUALITY, MALE; HUMANS; INDIA; MALE; MOTIVATION; PATIENT PARTICIPATION;

EID: 84908056391     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.08.043     Document Type: Article

References (41)

1. National AIDS Control Organisation Annual report 2012-13. NACO website 2013 (March), National AIDS Control Organisation, Available at: http://www.naco.gov.in/upload/Publication/Annual%20Report/Annual%20report%202012-13_English.pdf [accessed 2 July 2014].
2. National AIDS Control Organisation HIV sentinel surveillance 2012-13: a technical brief. NACO web site 2012, National AIDS Control Organisation, Available at: http://www.naco.gov.in/upload/NACP%20-%20IV/HSS%20TECHNICAL%20BRIEF/HIV%20Sentinel%20Surveillance%20Technical%20Brief.pdf [accessed 2 July 2014].
3. International AIDS Vaccine Initiative THSTI & IAVI announce new HIV vaccine design program in India. IAVI web site 2011 (March), International AIDS Vaccine Initiative, Available at: http://www.iavi.org/Information-Center/Press-Releases/Pages/THSTI-IAVI-Announce-New-HIV-Vaccine-Design-Program-in-India.aspx [accessed 2 July 2014].
4. International AIDS Vaccine Initiative Clinical trials database: database of vaccine candidates in clinical trials. IAVI web site 2014 (May), International AIDS Vaccine Initiative, Available at: http://www.iavireport.org/Trials-Database/Pages/Results.aspx?searchid=bf120aa8-d0fa-4139-929d-33d2c0ae0198 [accessed 2 July 2014].
5. Mehendale S., van Lunzen J., Clumeck N., Rockstroh J., Vets E., Johnson P.R., et al. A phase 1 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 subtype C adeno-associated virus vaccine. AIDS Res Hum Retroviruses 2008, 24:873-880.
6. Van Lunzen J., Mehendale S., Clumeck N., Vets E., Rockstroh J., Anklesaria P., et al. A phase I Study to evaluate the safety and immunogenicity of a recombinant adeno-associated virus HIV vaccine. 14th Conference on retroviruses and opportunistic infections 2007, 25-28.
7. Ramanathan V.D., Kumar M., Mahalingam J., Narayanan P.R., Solomon S., Boaz M., et al. A Phase 1 study to evaluate the safety and immunogenicity of a recombinant modified vaccinia ankara virus (TBC-M4) multigenic HIV subtype C Vaccine. AIDS Vaccine 2007, 24:20-23.
8. Mehendale S., Thakar M., Sahay S., Kumar M., Shete A., Sathyamurthi P., et al. Safety and immunogenicity of DNA and MVA HIV-1 subtype C vaccine prime-boost regimens: a phase I randomised Trial in HIV-uninfected Indian volunteers. PLoS One 2013, 8(2):e55831.
9. Dhalla S., Poole G. Motivators of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies. AIDS Care 2011, 23(11):1430-1447.
10. Dhalla S., Poole G. Barriers of enrolment in HIV vaccine trials: a review of HIV vaccine preparedness studies. Vaccine 2011, 29:5850-5859.
11. Mills E., Cooper C., Guyatt G., Gilchrist A., Rachlis B., Sulway C., et al. Barriers to participating in an HIV vaccine trial: a systematic review. AIDS 2004, 18(17):2235-2242.
12. Jenkins R.A., Torugsa K., Markowitz L.E., Mason C.J., Jamroentana V., Brown A.E., et al. Willingness to participate in HIV-1 vaccine trials among young Thai men. Sex Transm Infect 2000, 76(5):386-392.
13. Nyamathi A.M., Suhadev M., Swaminathan S., Fahey J.L. Perceptions of a community sample about participation in future HIV vaccine trials in south India. AIDS Behav 2007, 11(4):619-627.
14. Suhadev M., Nyamathi A.M., Swaminathan S., Suresh A., Venkatesan P. Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India. AIDS Res Hum Retroviruses 2009, 25(2):217-224.
15. Sahay S., Mehendale S., Sane S., Brahme R., Brown A., Charron K., et al. Correlates of HIV vaccine trial participation: an Indian perspective. Vaccine 2005, 23:1351-1358.
16. Suhadev M., Nyamathi A.M., Swaminathan S., Venkatesan P., Raja Sakthivel M., Shenbagavalli R., et al. A pilot study on willingness to participate in future preventative HIV vaccine trials. Indian J Med Res 2006, 124(6):631-640.
17. Chakrapani V., Newman P.A., Singhal N., Nelson R., Shunmugam M. "If it's not working, why would they be testing it?": mental models of HIV vaccine trials and preventive misconception among men who have sex with men in India. BMC Public Health 2013, 13:731.
18. Godfrey C., Schouten J.T., Swindells S. Implementation of HIV-related clinical research in the international setting. J Acquir Immune Defic Syndr 2014, 65(Suppl 1):S1-S2.
19. Moodley K. HIV vaccine trial participation in South Africa-an ethical assessment. J Med Philos 2002, 27:197-215.
20. Loue S., Okello D., Kawuma M. Research bioethics in the Ugandan context: a program summary. J Law Med Ethics 1996, 24:53-57.
21. Streefland P.H. Introduction of a HIV vaccine in developing countries: social and cultural dimensions. Vaccine 2003, 21:9-1304.
22. Benatar S.R. Reflections and recommendations on research ethics in developing countries. Soc Sci Med 2002, 54:41-1131.
23. Glickman S.W., McHutchison J.G., Peterson E.D., Cairns C.B., Harrington R.A., Califf R.M., et al. Ethical and scientific implications of the globalization of clinical research. N Engl J Med 2009, 360:23-816.
24. Singh J., Mills E. The abandoned trials of pre-exposure prophylaxis for HIV: what went wrong?. PLoS Med 2005, 2(9):e234.
25. Newman P.A. Towards a science of community engagement. Lancet 2006, 367(9507):302.
26. UNAIDS-AVAC Good participatory practice: guidelines for biomedical HIV prevention trials 2011. AVAC web site 2011 (June), UNAIDS-AVAC, Available at: http://www.avac.org/sites/default/files/resource-files/Good%20Participatory%20Practice%20guidelines_June_2011.pdf [accessed 2 July 2014].
27. Ciaranello A.L., Walensky R.P., Sax P.E., Chang Y., Freedberg K.A., Weissman J.S. Access to medications and medical care after participation in HIV clinical trials: a systematic review of trial protocols and informed consent documents. HIV Clin Trials 2009, 10(1):13-24.
28. Guenter D., Esparza J., Macklin R. Ethical considerations in international HIV vaccine trials: summary of a consultative process conducted by the Joint United Nations Programme on HIV/AIDS (UNAIDS). J Med Ethics 2000, 26:37-43.
29. Flory J., Emanuel E.J. Interventions to improve research participants' understanding in informed consent for research: a systematic review. JAMA 2004, 292:1593-1601.
30. Emanuel E.J., Currie X.E., Herman A. Undue inducement in clinical research in developing countries: is it a worry?. Lancet 2005, 40-366.
31. National AIDS Control Organisation HIV sentinel surveillance 2012-13: a technical brief. NACO web site 2013, National AIDS Control Organisation, Available at: http://www.naco.gov.in/upload/NACP%20-%20IV/HSS%20TECHNICAL%20BRIEF/HIV%20Sentinel%20Surveillance%20Technical%20Brief.pdf [accessed 2 July 2014].
32. MacKellar D.A., Gallagher K.M., Finlayson T., Sanchez T., Lansky A., Sullivan P.S. Surveillance of HIV risk and prevention behaviours of men who have sex with men-a national application of venue-based, time-space sampling. Public Health Rep 2007, 122(Suppl 1):39-47.
33. Chakrapani V., Newman P.A., Singhal N., Jerajani J., Shunmugan M. Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai. India: a social ecological approach. PLoS One 2012, 7(12):e51080.
34. Rao J.N.K., Scott A.J. On chi-squared tests for multiway contingency tables with cell proportions estimated from survey data. Ann Statist 1984, 12:46-60.
35. Duerr A., Huang Y., Buchbinder S., Coombs R.W., Sanchez J., del Rio C., et al. Extended follow-up confirms early vaccine-enhanced risk of HIV acquisition and demonstrates waning effect over time among participants in a randomized trial of recombinant adenovirus HIV vaccine (Step Study). J Infect Dis 2012, 206:66-258.
36. Newman P.A., Logie C., James L., Charles T., Maxwell J., Salam K., et al. Speaking the dialect": understanding public discourse in the aftermath of an HIV vaccine trial shutdown. Am J Public Health 2011, 101:58-1749.
37. Brahmam G.N., Kodavalla V., Rajkumar H., Rachakulla H.K., Kallam S., Myakala S.P., et al. Sexual practices, HIV and sexually transmitted infections among self-identified men who have sex with men in four high HIV prevalence states of India. AIDS 2008, 22(Suppl 5):S45-S57.
38. National AIDS Control Organisation Targeted interventions under NACP III: operational guidelines volume I-core high risk groups. NACO web site 2007 (October), National AIDS Control Organisation, Available at: http://www.iapsmgc.org/userfiles/3TARGETED_INTERVENTION_FOR_HIGH_RISK_GROUP.pdf [accessed 2 July 2014].
39. Jesani A. New regulations on compensation for injury and death in drug trials. Indian J Med Ethics 2013, 10(2):9-76.
40. Shukla S. India's amended trial regulations spark research exodus. Lancet 2013, 382(9895):845.
41. Hosek S.G., Zimet G.D. Behavioural considerations for engaging youth in HIV clinical research. J Acquir Immune Defic Syndr 2010, 54(Suppl 1):S25-S30.